MX156087A - Procedimiento para la preparacion de derivados de piperazino-2-pirimidinas - Google Patents
Procedimiento para la preparacion de derivados de piperazino-2-pirimidinasInfo
- Publication number
- MX156087A MX156087A MX192097A MX19209782A MX156087A MX 156087 A MX156087 A MX 156087A MX 192097 A MX192097 A MX 192097A MX 19209782 A MX19209782 A MX 19209782A MX 156087 A MX156087 A MX 156087A
- Authority
- MX
- Mexico
- Prior art keywords
- pirimidines
- piperazino
- derivatives
- procedure
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8106924A FR2503162A1 (fr) | 1981-04-07 | 1981-04-07 | Nouveaux derives de piperazino-2 pyrimidine, procedes pour leur preparation et leur utilisation comme medicaments ou comme intermediaires pour la fabrication de medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
MX156087A true MX156087A (es) | 1988-07-04 |
Family
ID=9257094
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX192097A MX156087A (es) | 1981-04-07 | 1982-04-01 | Procedimiento para la preparacion de derivados de piperazino-2-pirimidinas |
Country Status (21)
Country | Link |
---|---|
US (1) | US4535080A (es) |
EP (1) | EP0063509B1 (es) |
JP (1) | JPS57179167A (es) |
AR (1) | AR231442A1 (es) |
AT (1) | AT386199B (es) |
AU (1) | AU549748B2 (es) |
CA (1) | CA1175427A (es) |
DE (1) | DE3262374D1 (es) |
DK (1) | DK156722C (es) |
ES (4) | ES8306745A1 (es) |
FI (1) | FI78909C (es) |
FR (1) | FR2503162A1 (es) |
GR (1) | GR77331B (es) |
HU (1) | HU187673B (es) |
IE (1) | IE52872B1 (es) |
IL (1) | IL65422A (es) |
MA (1) | MA19438A1 (es) |
MX (1) | MX156087A (es) |
NO (1) | NO158739C (es) |
PT (1) | PT74712B (es) |
ZA (1) | ZA822344B (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3305524A1 (de) * | 1983-02-18 | 1984-08-23 | Celamerck Gmbh & Co Kg, 6507 Ingelheim | Neue pyrimidinderivate |
DE3321969A1 (de) * | 1983-06-18 | 1984-12-20 | Troponwerke GmbH & Co KG, 5000 Köln | 2-pyrimidinyl-1-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel |
JPS6143173A (ja) * | 1984-08-06 | 1986-03-01 | Mitsui Petrochem Ind Ltd | 新規ピリミジン誘導体およびその製法 |
DE3752141T2 (de) * | 1986-02-24 | 1998-03-26 | Mitsui Petrochemical Ind | Mittel zur behandlung von neuropathie |
JP2561689B2 (ja) * | 1986-02-24 | 1996-12-11 | 三井石油化学工業株式会社 | 神経疾患用治療薬 |
WO1989000423A1 (en) | 1987-07-09 | 1989-01-26 | Pfizer Inc. | 2-amino-5-hydroxy-4-pyrimidones |
US4910204A (en) * | 1988-06-28 | 1990-03-20 | Pfizer Inc. | 2-amino-5-hydroxy-4-pyrimidones |
FI895821A0 (fi) * | 1988-12-07 | 1989-12-05 | Wellcome Found | Farmaceutiskt aktiva cns foereningar. |
CN101437843B (zh) * | 2006-01-23 | 2013-08-07 | 密歇根州立大学评议会 | 抗草甘膦植物的育种方法及组合物 |
US8697694B2 (en) * | 2008-08-20 | 2014-04-15 | Merck Sharp & Dohme Corp. | Substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
BRPI1011058A2 (pt) * | 2009-05-19 | 2015-08-25 | Dow Agrosciences Llc | Compostos e metodos controlar fungos |
CN103204816B (zh) | 2012-01-16 | 2016-04-27 | 中国人民解放军军事医学科学院毒物药物研究所 | 哌嗪基嘧啶类衍生物及其制备方法和用途 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE485737A (es) * | 1947-11-12 | |||
FR2257294B1 (es) * | 1973-07-06 | 1977-07-01 | Ugine Kuhlmann | |
NL129219C (es) * | 1965-12-16 | |||
US3980781A (en) * | 1966-03-31 | 1976-09-14 | Imperial Chemical Industries Limited | Fungicidal composition and method containing 2-amino-pyrimidines |
FR2173746B1 (es) * | 1972-03-01 | 1975-04-25 | Ugine Kuhlmann | |
FR2244520B1 (es) * | 1973-07-06 | 1977-02-04 | Ugine Kuhlmann | |
JPS578104B2 (es) * | 1973-09-20 | 1982-02-15 | ||
GB1523274A (en) * | 1974-08-05 | 1978-08-31 | Ici Ltd | Herbicidal compositions containing substituted pyrimidine |
US4166852A (en) * | 1974-08-09 | 1979-09-04 | Produits Chimiques Ugine Kuhlmann | Piperazino-pyrimidines and their use as spasmolytic agents |
FR2281117A2 (fr) * | 1974-08-09 | 1976-03-05 | Ugine Kuhlmann | Nouvelles piperazino-pyrimidines utilisables comme medicaments |
FR2311776A1 (fr) * | 1975-05-23 | 1976-12-17 | Sogeras | Diamino-2,4 bromo-5 chloro-6 pyrimidines et procede pour leur preparation |
FR2417507A2 (fr) * | 1977-07-28 | 1979-09-14 | Ugine Kuhlmann | Diamino-2,4 (ou -4,6) methylthio-5 pyrimidines herbicides |
-
1981
- 1981-04-07 FR FR8106924A patent/FR2503162A1/fr active Granted
-
1982
- 1982-03-11 GR GR67575A patent/GR77331B/el unknown
- 1982-03-26 DE DE8282400551T patent/DE3262374D1/de not_active Expired
- 1982-03-26 EP EP82400551A patent/EP0063509B1/fr not_active Expired
- 1982-03-31 AT AT0127682A patent/AT386199B/de not_active IP Right Cessation
- 1982-04-01 MX MX192097A patent/MX156087A/es unknown
- 1982-04-01 IE IE774/82A patent/IE52872B1/en unknown
- 1982-04-05 DK DK154382A patent/DK156722C/da not_active IP Right Cessation
- 1982-04-05 MA MA19642A patent/MA19438A1/fr unknown
- 1982-04-05 ZA ZA822344A patent/ZA822344B/xx unknown
- 1982-04-05 AR AR289012A patent/AR231442A1/es active
- 1982-04-05 IL IL65422A patent/IL65422A/xx unknown
- 1982-04-06 FI FI821203A patent/FI78909C/fi not_active IP Right Cessation
- 1982-04-06 NO NO821159A patent/NO158739C/no unknown
- 1982-04-06 ES ES511224A patent/ES8306745A1/es not_active Expired
- 1982-04-06 PT PT74712A patent/PT74712B/pt unknown
- 1982-04-06 JP JP57057179A patent/JPS57179167A/ja active Pending
- 1982-04-07 AU AU82450/82A patent/AU549748B2/en not_active Ceased
- 1982-04-07 CA CA000400630A patent/CA1175427A/fr not_active Expired
- 1982-04-07 HU HU821067A patent/HU187673B/hu not_active IP Right Cessation
-
1983
- 1983-01-13 ES ES518974A patent/ES518974A0/es active Granted
- 1983-01-13 ES ES518975A patent/ES8400428A1/es not_active Expired
- 1983-01-13 ES ES518976A patent/ES518976A0/es active Granted
- 1983-08-24 US US06/525,799 patent/US4535080A/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES520180A0 (es) | Procedimiento para la preparacion de nuevos derivados de la aminometil-5-aril-3-oxazolidinona-2. | |
AR231637A1 (es) | Procedimiento para la preparacion de derivados substituidos de la piridazina | |
MX6802E (es) | Procedimiento para la preparacion de derivados carboestirilicos | |
MX7419E (es) | Procedimiento para la preparacion de pss-asa | |
ES524997A0 (es) | Procedimiento para la preparacion de derivados de la desoxiuridina | |
AR231537A1 (es) | Procedimiento para la preparacion de derivados de la piridazina | |
MX157607A (es) | Procedimiento para la preparacion de ciclohexilamina | |
AR231288A1 (es) | Procedimiento para la preparacion de 3-amido-n-/2-5-dimetilaminometil-furan-2-il-metiltio etil-benzamidas | |
MX156087A (es) | Procedimiento para la preparacion de derivados de piperazino-2-pirimidinas | |
AR227906A1 (es) | Procedimiento para la preparacion de derivados de 1-fenil-2-ciclohexen-1-alquilamina | |
ES501535A0 (es) | Procedimiento para la preparacion de derivados de alquilfos-fonito | |
MX157777A (es) | Procedimiento para la preparacion de derivados de ascoclorina | |
ES503407A0 (es) | Procedimiento para la preparacion de derivados de pirimidina | |
ES499729A0 (es) | Procedimiento para la preparacion de derivados de fenoxi- aminopropanol | |
ES501736A0 (es) | Procedimiento para la preparacion de derivados de 2-guanidi-notiazol | |
ES517288A0 (es) | Procedimiento para la preparacion de derivados de azolil-penteno. | |
AR229890A1 (es) | Procedimiento para la preparacion de 1-carvona | |
ES505576A0 (es) | Procedimiento para la preparacion de derivados de 7-oxopros-taciclina | |
ES499356A0 (es) | Procedimiento para la preparacion de derivados de rifamicina | |
ES525034A0 (es) | Procedimiento para la preparacion de derivados de 28-metil-brassinolidas | |
ES534337A0 (es) | Procedimiento para la preparacion de derivados de acridanona | |
ES517830A0 (es) | Procedimiento para la preparacion de derivados ergoticos. | |
ES505037A0 (es) | Procedimiento para la preparacion de derivados de aminotio- les | |
ES525035A0 (es) | Procedimiento para la preparacion de derivados de brassinoesteroides | |
AR229374A1 (es) | Procedimiento para la preparacion de 2-hidroximetil-3-hidroxi-6-(1-hidroxi-2-t-butilaminoetil)-piridina |